Actively Recruiting
A Prospective Registry for Patients at High-Risk for Pancreatic Cancer
Led by Mayo Clinic · Updated on 2026-03-10
5000
Participants Needed
1
Research Sites
524 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to facilitate discovery and validation of tests for early detection in subjects at high risk for pancreatic ductal adenocarcinoma (PDAC) and to facilitate the use of state-of-the-art machine learning-based algorithms that utilize databases and images with the purpose of identifying early stages of pancreatic cancer, as well as people at high-risk.The study also aims to provide a platform for development of an interventional protocol for early detection of PDAC.
CONDITIONS
Official Title
A Prospective Registry for Patients at High-Risk for Pancreatic Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 63 18 years
- Able to provide written informed consent
- Meets criteria as a High-Risk Individual as defined by protocol
You will not qualify if you...
- Personal history of pancreatic ductal adenocarcinoma (PDAC)
- History of total pancreatectomy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905
Actively Recruiting
Research Team
C
Clinical Trials Referral Office
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here